Your browser does not fully support modern features. Please upgrade for a smoother experience.
Serine Protease Inhibitors: Comparison
Please note this is a comparison between Version 1 by Yu Peng and Version 2 by Yu Peng.

Serine protease inhibitors are molecules that reduce peptide-bond hydrolysis by proteases whose catalytic mechanism uses a serine residue as the nucleophile [1][2]. They include small organic compounds and inhibitory proteins with distinct binding mechanisms [1][3]. Electrophilic inhibitors can react with the catalytic serine to form covalent complexes, whereas noncovalent inhibitors obstruct substrate recognition or access to the catalytic machinery [1][2]. Serpins inhibit through a coupled cleavage and conformational rearrangement: the protease attacks an exposed reactive loop, which subsequently inserts into the inhibitor's central beta sheet. This movement displaces and distorts the tethered protease, trapping the enzyme in an inactive complex [3]. Other protein inhibitors achieve inhibition through tight binding without this extensive structural transition; tick anticoagulant peptide selectively inhibits coagulation factor Xa [4]. Recognition of residues surrounding the scissile bond and contacts outside the catalytic center contribute to selectivity, so inhibition of one serine protease does not imply equivalent inhibition of the entire enzyme family [1][4].

  • serine protease
  • serpin
  • catalytic serine
  • protease inhibition

Protein Degradation and Inhibitors • Molecular Biology • Biochemistry, Genetics and Molecular Biology • Life Sciences

References

  1. Daniel A. Bachovchin; Benjamin F. Cravatt; The pharmacological landscape and therapeutic potential of serine hydrolases. Nat. Rev. Drug Discov. 2012, 11, 52-68. [CrossRef]
  2. James C. Powers; Juliana L. Asgian; Özlem Doǧan Ekici; Karen Ellis James; Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases. Chem. Rev. 2002, 102, 4639-4750. [CrossRef]
  3. James A. Huntington; Randy J. Read; Robin W. Carrell; Structure of a serpin–protease complex shows inhibition by deformation. Nature 2000, 407, 923-926. [CrossRef]
  4. Lloyd Waxman; Donna E. Smith; Karen E. Arcuri; Geroeg P. Vlasuk; Tick Anticoagulant Peptide (TAP) Is a Novel Inhibitor of Blood Coagulation Factor Xa. Science 1990, 248, 593-596. [CrossRef]
More
Write an Entry